Olig2+/NG2+/BLBP+ astrocyte progenitors: a novel component of the neurovascular unit in the developing mouse hippocampus
Astrocytes are key components of the neurovascular unit. While we have recently identified Olig2+ astrocyte progenitors (ASPs) in the developing mouse dentate gyrus (DG), their molecular signature remains incompletely characterized. Here we demonstrate that Olig2+ ASPs predominantly express brain lipid-binding protein (BLBP), while only a small population of them expresses <i>gfap</i>-GFP. These Olig2+/BLBP+ ASPs co-express the transcription factors Sox3, Sox9 and the proteoglycan NG2 but not Sox10, a marker for oligodendrocyte progenitors (OLPs). Olig2+ ASPs appear from embryonic day 18 (E18) onwards and decline at postnatal day 14 (P14). Consistent with the proliferation of both Olig2+ and NG2+ glial cells after brain injury, intrauterine intermittent hypoxia (IH) led to an increase in Olig2+/NG2+/BLBP+ ASPs in the postnatal DG. IH also promoted both angiogenesis and vascular coupling of Olig2+/NG2+ ASPs. Our data suggest that IH-induced expression of HIF1a increases Olig2+/NG2+/BLBP+ ASPs in a cell non-autonomous manner. Our data also revealed increased vascular coupling of GFAP+ astrocytes following IH, while the number of GFAP+ astrocytes remains unchanged. Given that BLBP, Olig2 and NG2 are expressed in reactive astrocytes, our findings suggest that Olig2+/NG2+/BLBP+ ASPs represent a subtype of reactive astrocyte progenitors. Furthermore, the enhanced vascular coupling of Olig2+/NG2+/BLBP+ ASPs appears to be an adaptive response to hypoxic brain injury. This study provides new insights into the molecular characteristics of Olig2+/NG2+/BLBP+ ASPs and their potential role in the brain's response to hypoxic injury, contributing to our understanding of neurovascular unit dynamics in both development and pathological conditions.
Authors
- Tokiharu Takahashi (ORCID: https://orcid.org/0000-0002-5785-8660)
- Hiroki Sugimoto (ORCID: https://orcid.org/0000-0003-1614-6971)
- Akira Masui
- Yuuki Arai (ORCID: https://orcid.org/0009-0005-4258-5419)
- Aya Ogawa (ORCID: https://orcid.org/0000-0002-4422-2567)
- Hideyuki Maeda
- Hiroshi Shinohara (ORCID: https://orcid.org/0000-0003-3778-8869)
- Kumiko Kondo (ORCID: https://orcid.org/0000-0002-3572-7088)
- Kyoji Ohyama
- Shoichiro Omura
- T. Kawachi
- Natsumi Takayama
- Rina Ogawa
Institutions
- Tokyo Medical University (JP)
- The University of Osaka (JP)
Publication Details
- Journal
- Frontiers in Cellular Neuroscience
- Published
- 2024-10-17
- DOI
- https://doi.org/10.3389/fncel.2024.1464402
- Citations
- 2
- Primary Topic
- Cancer-related molecular mechanisms research
- Type
- article
- Field-Weighted Citation Impact
- 0.57
Funders
- Mitsui Sumitomo Insurance Welfare Foundation
- Japan Society for the Promotion of Science